Literature DB >> 11735336

Immune evasion by muscle-specific gene expression in dystrophic muscle.

D Hartigan-O'Connor1, C J Kirk, R Crawford, J J Mulé, J S Chamberlain.   

Abstract

Muscle tissue from Duchenne muscular dystrophy patients and the Dmd(mdx/mdx) (hereafter referred to as mdx) mouse is characterized by an abundance of necrotic myofibers and infiltrating macrophages. Both features may provide additional stimulus to the immune response directed against novel antigens, such as those delivered by gene therapy vectors. It has previously been shown that the immune evasion achieved by adeno-associated virus in healthy muscle fails in one model of muscular dystrophy. Here, we examined the immune response to adenoviral vectors and their transgenes in normal and mdx mice. We found that mdx mouse muscles contain 20 times more macrophages and 7 times more dendritic cells than healthy muscles. This higher professional antigen-presenting cell content results in a stronger immune response to antigens that can be directly presented by those cells, including viral antigens and constitutively expressed transgene products. However, we did not detect a significant immune response to beta-galactosidase expressed specifically in muscle, even at high expression levels. This result suggests that cross-presentation is not more effective in mdx mouse muscle, and that targeted vectors and tissue-specific promoters may be useful tools for evasion of the immune response in dystrophic muscle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735336     DOI: 10.1006/mthe.2001.0496

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  24 in total

1.  Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

Authors:  Paul Gregorevic; Michael J Blankinship; James M Allen; Robert W Crawford; Leonard Meuse; Daniel G Miller; David W Russell; Jeffrey S Chamberlain
Journal:  Nat Med       Date:  2004-07-25       Impact factor: 53.440

Review 2.  Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Authors:  Jane T Seto; Julian N Ramos; Lindsey Muir; Jeffrey S Chamberlain; Guy L Odom
Journal:  Curr Gene Ther       Date:  2012-06       Impact factor: 4.391

Review 3.  Challenges for gene therapy for muscular dystrophy.

Authors:  Jerry R Mendell; K Reed Clark
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

4.  Morpholino-induced exon skipping stimulates cell-mediated and humoral responses to dystrophin in mdx mice.

Authors:  Maria C Vila; James S Novak; Margaret Benny Klimek; Ning Li; Melissa Morales; Alexander G Fritz; Katie Edwards; Jessica F Boehler; Marshall W Hogarth; Travis B Kinder; Aiping Zhang; Davi Mazala; Alyson A Fiorillo; Bonnie Douglas; Yi-Wen Chen; John van den Anker; Qi L Lu; Yetrib Hathout; Eric P Hoffman; Terence A Partridge; Kanneboyina Nagaraju
Journal:  J Pathol       Date:  2019-04-16       Impact factor: 7.996

5.  Intradermal Immunization with rAAV1 Vector Induces Robust Memory CD8+ T Cell Responses Independently of Transgene Expression in DCs.

Authors:  Alexandre Ghenassia; David-Alexandre Gross; Stéphanie Lorain; Fabiola Tros; Dominique Urbain; Sofia Benkhelifa-Ziyyat; Alain Charbit; Jean Davoust; Pascal Chappert
Journal:  Mol Ther       Date:  2017-07-15       Impact factor: 11.454

6.  Migration of dendritic cells from murine skeletal muscle.

Authors:  Lei Wang; Saman Eghtesad; Paula R Clemens
Journal:  Immunobiology       Date:  2010-05-21       Impact factor: 3.144

7.  Separating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in rats.

Authors:  David M Markusic; Dirk R de Waart; Jurgen Seppen
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression.

Authors:  En Kimura; Sheng Li; Paul Gregorevic; Brent M Fall; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2009-11-03       Impact factor: 11.454

9.  Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.

Authors:  En Kimura; Jay J Han; Sheng Li; Brent Fall; Jennifer Ra; Miki Haraguchi; Stephen J Tapscott; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2008-05-29       Impact factor: 6.150

10.  Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin.

Authors:  Christiana DelloRusso; Jeannine M Scott; Dennis Hartigan-O'Connor; Giovanni Salvatori; Catherine Barjot; Ann S Robinson; Robert W Crawford; Susan V Brooks; Jeffrey S Chamberlain
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.